title: Application of the RELY study to lifetime risks of atrial fibrillation: implications for spontaneous intracranial hemorrhage.
authors.forename: Phillip V
authors.initials: PV
authors.lastname: Parry
authors.forename: Johnathan A
authors.initials: JA
authors.lastname: Engh
mesh_terms: D000991:Antithrombins / Q000009:adverse effects*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D001562:Benzimidazoles / Q000009:adverse effects*; D000069604:Dabigatran; D006801:Humans; D020300:Intracranial Hemorrhages / Q000139:chemically induced*; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D015091:beta-Alanine / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000991:Antithrombins; D001562:Benzimidazoles; D015091:beta-Alanine; D000069604:Dabigatran